Mingqian Y. Li
Hangzhou, 310012, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Shuangpi formula treats neutrophilic asthma via circadian-mediated anti-inflammatory mechanisms.
Journal: Journal of ethnopharmacology
Published: April 01, 2026
Heterogeneity in adverse events associated with lumateperone: a study on potential subgroup-specific differences.
Journal: The international journal of neuropsychopharmacology
Published: July 13, 2025
Icariin modulates the tumor microenvironment in colorectal cancer by targeting M2 macrophage polarization via PI3K/AKT pathway.
Journal: Bioorganic & medicinal chemistry
Published: April 23, 2025
Corrigendum to "Isopimaric acid, an ion channel regulator, regulates calcium and oxidative phosphorylation pathways to inhibit breast cancer proliferation and metastasis" [Toxicology and applied Pharmacology, 2023, 462:116415].
Journal: Toxicology and applied pharmacology
Published: March 27, 2025
Calcium channels as pharmacological targets for cancer therapy.
Journal: Clinical and experimental medicine
Published: January 08, 2025
Corrigendum to ''Spinosad blocks CHRNA5 mediated EGFR signaling pathway activation to inhibit lung adenocarcinoma proliferation'' [Biomed. Pharma. 177 (2024) 117105].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 20, 2024
The anti-tumor effects of main component (benzethonium chloride) of butorphanol tartrate injection in non-small cell lung cancer.
Journal: Scientific reports
Published: August 12, 2024
Spinosad blocks CHRNA5 mediated EGFR signaling pathway activation to inhibit lung adenocarcinoma proliferation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 26, 2024
Sciadonic acid attenuates high-fat diet-induced bone metabolism disorders in mice.
Journal: Food & function
Published: April 03, 2024
Liquidambaric acid inhibits the proliferation of hepatocellular carcinoma cells by targeting PPARα-RXRα to down-regulate fatty acid metabolism.
Journal: Toxicology and applied pharmacology
Published: March 12, 2024
Last Updated: 09/26/2026